Duloxetine for the treatment of major depressive disorder in elderly patients: Outcomes in patients with comorbid arthritis.

被引：0
|
作者：
Hall, J
Wohlreich, M
Mallinckrodt, C
Chappell, A
Myers, T
Raskin, J
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Eli Lilly Canada, Scarborough, ON, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [41] Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder
    Shibata, Risa Yokokawa
    Kubota, Ryuji
    Uenaka, Kazunori
    Kaibara, Atsunori
    Wajima, Toshihiro
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2023, 51
  • [42] A comparison of initial duloxetine dosing strategies in patients with major depressive disorder
    Whitrayer, Virgil G.
    Dunner, David L.
    Kornstein, Susan G.
    Meyers, Adam L.
    Mallinckrodt, Craig H.
    Wohlreich, Madelaine M.
    Gonzales, Jill S.
    Greist, John H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (12) : 1921 - 1930
  • [43] Duloxetine-Induced Liver Injury in Patients with Major Depressive Disorder
    Kang, Seung-Gul
    Park, Young-Min
    Lee, Heon-Jeong
    Yoon, Byungmun
    [J]. PSYCHIATRY INVESTIGATION, 2011, 8 (03) : 269 - 271
  • [44] A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder
    Perahia, David G. S.
    Pritchett, Yili Lu
    Kajdasz, Daniel K.
    Bauer, Michael
    Jain, Rakesh
    Russell, James M.
    Walker, Daniel J.
    Spencer, Kimberly A.
    Froud, Debbie M.
    Raskin, Joel
    Thase, Michael E.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (01) : 22 - 34
  • [45] Continuation treatment of major depressive disorder: is there a case for duloxetine?
    Norman, Trevor R.
    Olver, James S.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 : 19 - 31
  • [46] FDA approves duloxetine for the treatment of major depressive disorder
    不详
    [J]. CNS SPECTRUMS, 2004, 9 (09) : 633 - 633
  • [47] Duloxetine treatment of social anxiety disorder with comorbid major depression
    Lin, Chao-Cheng
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (05) : 591 - 592
  • [48] PREDICTORS FOR DULOXETINE TREATMENT FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN VETERANS AFFAIRS HEALTH CARE NETWORK
    Shi, L.
    Liu, J.
    Zhao, Y.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A365 - A365
  • [49] Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder
    Clayton, Anita
    Kornstein, Susan
    Prakash, Apurva
    Mallinckrodt, Craig
    Wohlreich, Madelaine
    [J]. JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04): : 917 - 929
  • [50] Comparisons of the Efficacy and Safety of Duloxetine for the Treatment of Fibromyalgia in Patients With Versus Without Major Depressive Disorder
    Arnold, Lesley M.
    Hudson, James I.
    Wang, Fujun
    Wohlreich, Maldelaine M.
    Prakash, Apurva
    Kajdasz, Daniel K.
    Chappell, Amy S.
    [J]. CLINICAL JOURNAL OF PAIN, 2009, 25 (06): : 461 - 468
12345